EUVIMEDEUVIMED entdecken
Crossref

Computational Evaluation of Scopoletin Against Diabetes-Related Targets: Insights from Molecular Docking and Molecular Dynamics Studies

Tanzila A. Kazi, Gurunath V. Mote, Vikramsingh Ingale, S. B. Wakshe

International Journal of Drug Delivery Technology · 14.07.2026 · 16 (64s)

DOI: 10.25258/ijddt.16.64s.53 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.07.2026. Verfasst von Tanzila A. Kazi und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia and associated complications. The search for safer and more effective antidiabetic agents has led to increasing interest in plant-derived bioactive compounds. The present study investigated the antidiabetic potential of scopoletin through molecular docking and molecular dynamics (MD) simulation approaches. Molecular docking was performed against five key antidiabetic targets, namely α-glucosidase (5NN3), α-amylase (1HNY), dipeptidyl peptidase-4 (DPP-4; 2ONC), PPARγ (6MS7), and pepsin (1PSO). Scopoletin exhibited favorable binding affinities with all target proteins, ranging from −5.9 to −7.2 kcal/mol. Among the investigated targets, DPP-4 (2ONC) demonstrated the strongest binding affinity (−7.2 kcal/mol), supported by hydrogen bonding and hydrophobic interactions within the active site. Consequently, the 2ONC–scopoletin complex was subjected to a 100 ns molecular dynamics simulation using the GROMACS platform. Stability of the complex was evaluated through RMSD, RMSF, radius of gyration (Rg), solvent-accessible surface area (SASA), and hydrogen bond analyses. The complex maintained stable RMSD values (~0.2 nm), low residue fluctuations, consistent Rg values (~2.7 nm), stable SASA profiles (~330 nm²), and a sustained hydrogen-bonding network throughout the simulation period. These findings indicate that scopoletin forms a stable and energetically favorable complex with DPP-4 without causing significant structural perturbations to the protein. Overall, the study highlights scopoletin as a promising natural antidiabetic candidate and supports its potential role as a multi-target inhibitor for diabetes management. Further in vitro and in vivo investigations are warranted to validate its therapeutic efficacy.

Zitieren

APA

Kazi, T. A., Mote, G. V., Ingale, V., & Wakshe, S. B. (2026). Computational Evaluation of Scopoletin Against Diabetes-Related Targets: Insights from Molecular Docking and Molecular Dynamics Studies. International Journal of Drug Delivery Technology, 16(64s). https://doi.org/10.25258/ijddt.16.64s.53

Vancouver

Kazi TA, Mote GV, Ingale V, Wakshe SB. Computational Evaluation of Scopoletin Against Diabetes-Related Targets: Insights from Molecular Docking and Molecular Dynamics Studies. International Journal of Drug Delivery Technology. 2026;16(64s). doi:10.25258/ijddt.16.64s.53

BibTeX
@article{Kazi2026,
  author = {Kazi, Tanzila A. and Mote, Gurunath V. and Ingale, Vikramsingh and Wakshe, S. B.},
  title = {Computational Evaluation of Scopoletin Against Diabetes-Related Targets: Insights from Molecular Docking and Molecular Dynamics Studies},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {64s},
  doi = {10.25258/ijddt.16.64s.53}
}
Kostenlos starten →